Necrotizing soft tissue infections

1. High-Yield Summary

• Surgical Emergency Definition: Necrotizing soft tissue infections (NSTIs) are rapidly progressive, life- and limb-threatening bacterial infections involving the skin, subcutaneous fat, and fascial compartments characterized by widespread microvascular thrombosis and liquefactive tissue necrosis.
• Cardinal Diagnostic Clue: Severe pain out of proportion to physical examination findings represents the earliest and most sensitive clinical hallmark; classic signs such as crepitus, skin bullae, and cutaneous necrosis are late manifestations of advanced, irreversible tissue demise.
• The LRINEC Fallacy: The Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) score carries a pooled sensitivity of only 68%; a score below 6 can never be utilized to exclude an NSTI or delay operative exploration.
• Operative Imperative: Emergent, radical surgical debridement of all non-viable tissue to bleeding margins combined with physiological resuscitation and broad-spectrum empiric antimicrobial therapy (including clindamycin for toxin suppression) is the definitive life-saving intervention.
• Mandatory Re-Exploration: A planned second-look surgical re-exploration within 12 to 24 hours is mandatory, as initial debridement rarely achieves complete clearance of evolving fascial necrosis.

2. Anatomy

The musculoskeletal anatomy governing the rapid dissemination of necrotizing infections centers upon the superficial and deep fascial planes. The superficial fascia (hypodermis) comprises loose areolar connective tissue and adipose matrix, whereas the deep investing fascia forms a dense, relatively avascular fibrous collagenous envelope surrounding individual muscle groups and osseous compartments. Because the deep fascial clefts lack internal anatomical barriers and exhibit low intrinsic vascularity, bacterial proliferation and enzymatic liquefaction propagate horizontally along these planes of least resistance with remarkable velocity, often advancing tens of centimeters before vascular compromise manifests in the overlying skin.

The cutaneous blood supply is fundamentally dependent on perforating musculo- and septocutaneous arterioles that traverse the deep fascia and subcutaneous fat. In NSTIs, bacterial exotoxins, platelet-leukocyte aggregation, and intense local inflammation induce septic microvascular thrombosis (endarteritis obliterans) within these perforating vessels. As the nutrient perforators thrombose, the superficial skin is deprived of perfusion, culminating in secondary ischemic epidermolysis, bullae formation, and full-thickness dermal gangrene.

Extensile surgical exploration requires precise knowledge of regional neurovascular danger zones and intermuscular planes:

• Upper Extremity Danger Zones: In the volar forearm, the radial and ulnar arteries, along with the median and ulnar nerves, lie directly deep to the antebrachial fascia and between superficial and deep flexor muscle bellies; extensile longitudinal incisions must follow Henry’s approach or the volar-ulnar approach while avoiding transverse cuts across the wrist flexion crease. In the upper arm and axilla, the brachial neurovascular bundle and median nerve must be identified and protected during circumferential medial fascial releases.
• Lower Extremity Danger Zones: In the leg, the anterior tibial artery and deep peroneal nerve rest directly on the interosseous membrane in the anterior compartment, while the superficial peroneal nerve pierces the crural fascia in the distal lateral compartment; release of the anterior, lateral, superficial posterior, and deep posterior compartments via dual extensile medial and anterolateral incisions is required if concomitant compartment syndrome develops. In the femoral triangle and popliteal fossa, major axial vascular conduits (femoral and popliteal vessels) must be protected during radical fasciotomies.
• Perineal and Trunk Boundaries: In Fournier gangrene, Colles’ fascia of the perineum is continuous with Dartos fascia of the scrotum/penis and Scarpa’s fascia of the anterior abdominal wall, allowing rapid trans-compartmental ascent into the retroperitoneum and thoracic wall.

3. Pathogenesis

Necrotizing soft tissue infections encompass a distinct pathophysiological cascade characterized by microbial invasion, hypervirulent toxin elaboration, endarteritis obliterans, and rapid liquefactive necrosis of connective tissue planes. The condition is broadly classified into distinct microbiological categories that dictate both clinical behavior and antimicrobial selection:

• Type I (Polymicrobial / Synergistic): Accounts for 70% to 80% of all NSTIs. It involves a synergistic mixture of obligate anaerobes (Bacteroides species, Peptostreptococcus, Clostridium species) and facultative aerobes (Enterobacteriaceae such as Escherichia coli, Klebsiella pneumoniae, and Proteus species, along with non-Group A Streptococci and Enterococci). Facultative aerobes consume local oxygen and lower tissue oxidation-reduction potential, creating an ideal microenvironment for anaerobic proliferation. Anaerobic bacteria subsequently synthesize collagenases, heparinases, and hyaluronidases that degrade extracellular matrices and hydrolyze fascial collagen, promoting rapid bacterial tracking along tissue planes. Gas production is frequently present in Type I infections due to anaerobic glucose fermentation.
• Type II (Monomicrobial): Accounts for 20% to 30% of cases and is predominantly caused by Streptococcus pyogenes (Group A beta-hemolytic Streptococcus [GAS]), either alone or in combination with Staphylococcus aureus (including methicillin-resistant S. aureus [MRSA]). Unlike Type I, Type II infections frequently afflict younger, immunocompetent hosts following minor trauma, surgical incisions, or blunt musculoskeletal contusions. S. pyogenes elaborates potent virulence factors including M-protein (which resists phagocytosis and binds fibrinogen) and Streptococcal Pyrogenic Exotoxins (SpeA, SpeB, SpeC). SpeA and SpeC function as classical superantigens, binding directly to class II major histocompatibility complex (MHC) molecules and T-cell receptors without normal antigen processing, eliciting massive polyclonal T-cell activation and an uncontrolled cytokine storm (TNF-α, IL-1β, IL-6, IFN-γ) that drives systemic capillary leak, refractory septic shock, and multiorgan failure.
• Type III (Gram-Negative Marine / Aquatic): Caused by halophilic marine organisms, most notably Vibrio vulnificus and Aeromonas hydrophila. Transmission occurs via skin lacerations exposed to warm saltwater, raw oyster handling, or contaminated freshwater. V. vulnificus produces potent metalloproteinases and cytolysins that trigger fulminant soft tissue destruction, hemorrhagic bullae, and early bacteremic septic shock with mortality exceeding 50% in patients with underlying chronic liver disease or hemochromatosis.
• Type IV (Fungal): Caused by invasive zygomycetes (Mucor, Rhizopus) and Aspergillus species. This entity occurs primarily in severely immunocompromised individuals, major blast injuries, severe burn trauma, or high-energy agricultural crush injuries. Fungal hyphae actively invade arterial walls, causing rapid thrombosis and extensive ischemic necrosis.

As the infectious process advances, extensive microvascular thrombosis causes ischemia of deep muscular fascia and subcutaneous adipose tissue. The combination of tissue hypoxia, inflammatory capillary leakage, and purulent exudate elevates interstitial pressures within closed osteofascial compartments, frequently inducing secondary limb compartment syndrome and downstream myonecrosis.

4. Natural History

The natural history of an untreated necrotizing soft tissue infection is uniform and catastrophic: uninhibited bacterial proliferation and exotoxin release lead to progressive systemic inflammatory response syndrome (SIRS), severe septic shock, disseminated intravascular coagulation (DIC), multiorgan dysfunction syndrome (MODS), and death within 24 to 72 hours of onset.

The global incidence of NSTI is estimated between 0.4 and 1.5 cases per 100,000 person-years. Although the condition can affect individuals of any age, significant host risk factors substantially elevate vulnerability to Type I infections. These include diabetes mellitus (present in 50% to 70% of Type I cases), end-stage renal disease, chronic hepatic cirrhosis, peripheral arterial disease, obesity, systemic malnutrition, chronic corticosteroid therapy, and intravenous drug use. In contrast, Type II streptococcal necrotizing fasciitis frequently occurs in previously healthy individuals with no preexisting chronic medical conditions, often preceded by blunt muscle trauma or minor cutaneous abrasions.

Despite advances in critical care, contemporary overall mortality across global registry analyses remains between 15% and 25%. Time to operative intervention represents the single most significant modifiable prognostic determinant. Patients undergoing definitive surgical debridement within 12 hours of presentation demonstrate significantly lower mortality compared to those whose surgical management is delayed beyond 24 hours.

5. Clinical Presentation

History

Obtaining an accurate history is essential for recognizing host risk factors and potential exposure vectors. Clinicians must specifically inquire regarding:

• Onset and Progression: Exact time of symptom onset and rate of progression; symptoms that accelerate over hours rather than days strongly favor necrotizing infection over benign cellulitis.
• Inoculation Event: Recent penetrating trauma, minor abrasions, splinter or needle puncture wounds, insect bites, surgical interventions, intramuscular or subcutaneous injections, or blunt contusions.
• Environmental Exposures: Exposure to saltwater, raw shellfish, brackish marshes, or domestic freshwater sources (raising suspicion for Vibrio or Aeromonas).
• Systemic Toxic Symptoms: Profound malaise, rigors, confusion, dizziness, lightheadedness, or nausea out of proportion to typical localized skin infections.

Physical Examination

Physical examination findings evolve rapidly along a continuum from early, non-specific inflammatory signs to late, irreversible tissue necrosis:

• Pain Out of Proportion to Exam: The single most reliable early clinical indicator. The patient experiences exquisite, severe tenderness to light palpation extending well beyond the visible boundaries of cutaneous erythema.
• Early Cutaneous Signs: Ill-defined erythema, tense edema, warmth, and localized induration. These signs frequently mimic uncomplicated cellulitis, leading to hazardous diagnostic delays.
• Intermediate Signs: Progressive expansion of erythema that fails to respect anatomical boundaries or respond to intravenous antibiotics; evolution of deep, “woody” or brawny induration of the subcutaneous tissues.
• Late “Hard” Signs of Necrosis: Formation of fluid-filled bullae (clear bullae evolving into dusky violaceous or hemorrhagic bullae); cutaneous anesthesia (resulting from ischemic destruction of dermal nerve branches); patchy purple or black dermal gangrene; palpable subcutaneous crepitus (present in less than 30% of cases, reflecting gas-producing anaerobes); and frank hemodynamic instability (hypotension, tachycardia, altered mental status).
• Bedside Diagnostic “Finger Test”: Performed under local anesthesia at the bedside in equivocal cases. A 2-cm exploratory incision is carried down through the skin and subcutaneous tissue to the level of the deep fascia. A positive test is characterized by: (1) lack of normal bleeding from subcutaneous tissues, (2) drainage of murky, foul-smelling, brownish “dishwater” exudate, and (3) complete absence of normal fascial resistance to gentle blunt finger dissection along the deep fascial plane.

6. Imaging and Diagnostic Studies

Diagnostic evaluation must never delay urgent surgical consultation and operative exploration when clinical suspicion for an NSTI is elevated.

• Plain Radiographs: Useful as an immediate initial screening tool. Key findings include soft tissue swelling and the presence of gas dissecting along interfascial tissue planes. However, subcutaneous gas is identified on plain films in only 20% to 35% of patients (sensitivity 25% to 40%, specificity >90%). The absence of gas on plain radiographs can never be used to rule out an NSTI.
• Computed Tomography (CT) with Intravenous Contrast: The definitive imaging modality of choice in hemodynamically stable patients when diagnostic ambiguity exists. Pathognomonic CT findings include asymmetric fascial thickening (>3 mm), non-enhancement of deep fascial planes (reflecting devascularization and ischemia), fluid collections tracking along fascial clefts, extensive fat stranding, and soft tissue gas tracking within intermuscular compartments. Meta-analyses demonstrate a pooled sensitivity of 88.5% and specificity of 93.3% for contrast-enhanced CT.
• Magnetic Resonance Imaging (MRI): Characterized by high signal intensity within deep fascia on T2-weighted and STIR sequences, with non-enhancing fascial defects on contrast-enhanced T1 images indicating necrosis. Although highly sensitive (90% to 100%), MRI frequently overestimates disease extent by failing to differentiate non-necrotizing reactive inflammatory edema from true fascial necrosis (specificity 60% to 80%). The prolonged acquisition time and logistical challenges in monitoring critically unstable patients make MRI unfeasible in the acute setting.
• Point-of-Care Ultrasonography (POCUS): Useful at the bedside in the emergency department. Key sonographic features include cobblestoning of subcutaneous tissue, fluid accumulation tracking along deep fascial layers (the “Stafford sign,” defined as hypoechoic fluid collections ≥4 mm along the deep fascia), and bright hyperechoic foci with acoustic shadowing indicative of subcutaneous gas.
• Laboratory Evaluation & The LRINEC Score: Standard laboratory workup reveals marked leukocytosis with left shift, severe bandemia, profound lactic acidosis, hyponatremia, acute renal impairment, coagulopathy, and marked elevation of inflammatory biomarkers (C-reactive protein, procalcitonin). The Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) score was derived to stratify risk based on six admission laboratory variables:

Clinical Interpretation of the LRINEC Score: A total score of 6 or greater stratifies the patient into an intermediate-to-high probability category for necrotizing fasciitis. However, rigorous contemporary systematic reviews demonstrate that the pooled sensitivity of the LRINEC score is only 68.2%, resulting in a false-negative rate exceeding 30%. Consequently, a low LRINEC score (<6) can never be used to rule out an NSTI, and clinical judgment must remain preeminent.

7. Classification

Validated classification schemas categorize necrotizing soft tissue infections according to microbiological etiology, anatomical tissue depth, and specialized clinical syndromes, directly guiding surgical debridement and targeted antimicrobial therapy.

8. Treatment

Medical / Nonoperative

There is no standalone nonoperative management for necrotizing soft tissue infections; medical therapy serves strictly as aggressive physiologic stabilization in parallel with emergent operative debridement:

• Hemodynamic Resuscitation: In accordance with Surviving Sepsis Campaign guidelines, deliver an immediate 30 mL/kg intravenous bolus of balanced crystalloids within the first 3 hours. Invasive arterial monitoring and central venous access should be established rapidly. Norepinephrine is the first-line vasopressor to target a mean arterial pressure (MAP) ≥65 mmHg; vasopressin (0.03 units/min) is added for refractory distributive shock.
• Empiric Broad-Spectrum Antimicrobial Therapy: Administer within 1 hour of recognition without awaiting culture results:
  • MRSA Coverage: Vancomycin (15–20 mg/kg IV q8–12h, targeting an AUC/MIC ratio of 400–600) OR Daptomycin (6–8 mg/kg IV q24h).
  • Gram-Negative & Anaerobic Coverage: Piperacillin-tazobactam (3.375–4.5 g IV q6h or extended infusion) OR Meropenem (1 g IV q8h).
  • Toxin Suppression (Mandatory): Clindamycin (600–900 mg IV q8h). Clindamycin binds to the 50S ribosomal subunit, shutting down the synthesis of streptococcal pyrogenic exotoxins (SpeA, SpeB, SpeC) and M-protein. This effectively circumvents the “Eagle effect” (the loss of penicillin and beta-lactam bactericidal activity in dense bacterial populations during stationary growth phase).
  • Marine Exposure Regimen: Add Doxycycline (100 mg IV q12h) plus Ceftriaxone (2 g IV q24h) if seawater or raw oyster exposure is suspected.
• Intravenous Immunoglobulin (IVIG): May be considered as an adjuvant in severe streptococcal toxic shock syndrome refractory to vasopressor support to neutralize circulating streptococcal superantigens.

Operative

Urgent surgical debridement is the definitive life-saving intervention. The fundamental goals of surgery are: (1) immediate source control, (2) radical excision of all necrotic, non-viable skin, subcutaneous tissue, and fascia, (3) decompression of involved osteofascial compartments, and (4) collection of deep tissue specimens for urgent microbiological and histopathological analysis.

• Incision and Exposure: Make generous, extensile longitudinal incisions along the axis of the limb or involved anatomical region. Incisions must cross flexion creases obliquely or incorporate Z-plasty principles to prevent severe post-healing flexion contractures. Carry incisions down through skin and subcutaneous adipose tissue directly to the deep fascia.
• Radical Fascial Excision: Perform digital exploration along the deep fascial plane. All fascia that separates effortlessly with blunt finger dissection without normal resistance must be widely excised. Debridement must proceed circumferentially until healthy, adherent, bleeding fascia and vascular subcutaneous tissues are reached.
• Evaluation of Muscle Viability (The “4 Cs”): Skeletal muscle compartments must be systematically inspected using the classic criteria:
  • Color: Normal beefy red versus pale, brown, or black ischemic tissue.
  • Consistency: Firm, resilient, elastic tissue versus soft, friable, mushy architecture.
  • Contractility: Brisk mechanical contraction elicited by electrocautery stimulation.
  • Capacity to Bleed: Active, pulsatile punctate bleeding from fresh cut surfaces.
  Any non-contractile, dusky, or avascular muscle must be aggressively resected back to viable tissue.
• Microbiological Sampling: Collect deep tissue biopsies and purulent fluid using sterile syringes or tissue rongeurs for immediate Gram stain and aerobic/anaerobic cultures. Do not send superficial skin swabs.
• Wound Dressing: Copiously irrigate the debrided wound with warm sterile saline under low pressure. Pack the wound open with sterile moist gauze or apply Negative Pressure Wound Therapy (NPWT) with a non-adherent interface at low continuous negative pressure (75–125 mmHg). Primary closure is strictly contraindicated.
• Mandatory Planned Second-Look Debridement: A return to the operating room must be formally scheduled within 12 to 24 hours of the index procedure. Necrotizing infections invariably demonstrate dynamic border progression, and multiple operative debridements (typically 2 to 4 procedures) are required before an entirely clean, stable wound bed is achieved.
• Limb Amputation: Open guillotine amputation or disarticulation through healthy proximal tissue margins is indicated when there is: (1) circumferential full-thickness myonecrosis rendering the limb non-functional, (2) refractory septic shock with escalating vasopressor requirements where ongoing limb conservation jeopardizes patient survival, or (3) extensive neurovascular destruction that precludes functional salvage.

Indications & Contraindications

Absolute Indications for Emergent Surgical Exploration:

• Severe pain out of proportion to physical exam findings accompanied by systemic toxic signs.
• Presence of hard physical findings: skin bullae, cutaneous necrosis, subcutaneous crepitus, or local sensory anesthesia.
• Computed tomography demonstrating soft tissue gas or non-enhancing deep fascial planes.
• Rapidly spreading erythema and edema refractory to broad-spectrum intravenous antibiotic therapy.
• Positive bedside “finger test” demonstrating murky exudate and lack of fascial resistance.

Contraindications:

• There are no absolute medical contraindications to life-saving surgical debridement in a patient with an NSTI; active coagulopathy, severe acidosis, or hemodynamic instability require concurrent resuscitation in the operating room rather than delay of surgical intervention.
• Primary surgical wound closure at the index debridement is strictly contraindicated.

9. Outcome

Contemporary clinical outcomes in necrotizing soft tissue infections are defined by survival rates, limb preservation, and long-term functional recovery:

• Mortality Benchmarks: In specialized tertiary burn and trauma centers employing standardized clinical protocols, overall hospital mortality ranges from 15% to 22%. Independent predictors of mortality include age >65 years, septic shock on admission, elevated serum lactate (>4.0 mmol/L), severe base deficit (<-10 mEq/L), active malignancy, and delayed surgical debridement exceeding 24 hours from symptom onset.
• Limb Preservation: In extremity-isolated NSTIs, modern aggressive limb salvage protocols achieve limb preservation in 75% to 85% of cases. Early amputation is reserved for severe myonecrosis or refractory physiologic collapse.
• Reconstructive Course: Following definitive source control and wound bed granulation, soft tissue coverage requires staged reconstructive procedures in over 80% of survivors, including split-thickness skin grafting (STSG), local tissue rearrangement, and microvascular free tissue transfer.
• Long-Term Functional Disability: Survivors experience significant long-term physical and psychological morbidity. Musculoskeletal impairments include severe joint contractures, muscle weakness, chronic lymphedema, and neuropathic pain syndromes. Validated patient-reported outcome measures (e.g., Short Form-36, EQ-5D, DASH) demonstrate persistent deficits in physical functioning and high rates of clinical depression and post-traumatic stress disorder (PTSD).

10. Complications

Complications associated with necrotizing soft tissue infections are frequent, severe, and span intraoperative, early postoperative, and late reconstructive phases:

11. Pearls and Pitfalls

• The Diagnostic Pearl: Disproportionate pain is your most sensitive diagnostic tool. When an extremity looks like mild cellulitis but the patient cries out in agony with light touch, suspect necrotizing fasciitis immediately.
• The Imaging Pitfall: Never withhold or delay surgical exploration to obtain advanced imaging (CT or MRI) in a deteriorating patient. A normal plain radiograph does not rule out necrotizing fasciitis; subcutaneous gas is absent in over 65% of patients.
• The LRINEC Trap: Do not use a LRINEC score <6 as reassurance to avoid surgery. The score’s sensitivity is only 68%; one out of every three patients with surgically confirmed necrotizing fasciitis has a LRINEC score below 6.
• The Pharmacological Pearl: Always include clindamycin in your empiric antibiotic regimen. Clindamycin shuts down ribosomal protein synthesis, terminating the production of streptococcal superantigens (SpeA, SpeC) and circumventing the Eagle effect where cell-wall active beta-lactams lose bactericidal potency in dense bacterial concentrations.
• The Surgical Pearl: The bedside “finger test” takes 60 seconds and confirms the diagnosis. If your gloved finger slides along the deep fascia without normal anatomical resistance and dishwater fluid drains from the incision, roll directly to the operating room.
• The Re-Exploration Rule: Never assume a single debridement is curative. Plan the second-look procedure for 12 to 24 hours before leaving the operating room. What appears marginally viable today will often be frank gangrene tomorrow.

12. Controversy

Significant debate persists across surgical and critical care literature regarding several therapeutic and diagnostic facets of necrotizing soft tissue infections:

• Adjuvant Hyperbaric Oxygen Therapy (HBOT): Proponents argue that delivering 100% oxygen at 2.5 to 3.0 atmospheres absolute (ATA) enhances leukocyte bactericidal killing, inhibits alpha-toxin production in Clostridium species, and promotes tissue granulation. Recent large-scale systematic reviews indicate a statistically significant association between adjuvant HBOT and reduced in-hospital mortality. However, opponents emphasize the complete absence of randomized controlled clinical trials, the severe logistical risks of transporting unstable, mechanically ventilated patients to hyperbaric chambers, and the risk of delaying necessary re-debridements. Professional consensus dictates that HBOT should never delay primary surgical debridement or scheduled operative re-exploration.
• Utility of the LRINEC Score in Clinical Practice: While initially introduced as a highly sensitive and specific clinical prediction rule, multiple external validation studies and meta-analyses have revealed substantial diagnostic limitations, with sensitivities ranging from 43% to 68%. Many trauma societies now strongly advise against relying on the LRINEC score in emergency department triage algorithms, citing the unacceptable risk of false-negative misclassification and fatal delays in surgical consultation.
• Role of Intravenous Immunoglobulin (IVIG): The use of pooled IVIG in Type II streptococcal necrotizing fasciitis complicated by toxic shock syndrome remains controversial. Proponents highlight its capacity to neutralize circulating superantigens and downregulate excessive systemic cytokine release. European randomized and observational studies (e.g., the INSTINCT trial) yielded conflicting findings regarding 28-day survival benefit. Current guidelines consider IVIG an optional adjunctive therapy in refractory streptococcal shock rather than a universal standard of care.

13. Evidence-Based Synthesis

Modern clinical decision-making is grounded in high-quality randomized controlled trials and prospective registry analyses, corroborated by seminal biomechanical and anatomical descriptions.

14. References

• Fernando SM, Tran A, Cheng W et al. Necrotizing Soft Tissue Infection: Diagnostic Accuracy of Physical Examination, Imaging, and LRINEC Score: A Systematic Review and Meta-Analysis. Ann Surg. 2019. doi:10.1097/SLA.0000000000002774 [Level I: Systematic Review / Meta-Analysis]
• Dhanasekara CS, Marschke B, Morris E et al. Global patterns of necrotizing soft tissue infections: A systematic review and meta-analysis. Surgery. 2021. doi:10.1016/j.surg.2021.06.036 [Level I: Systematic Review / Meta-Analysis]
• Huang C, Zhong Y, Yue C et al. The effect of hyperbaric oxygen therapy on the clinical outcomes of necrotizing soft tissue infections: a systematic review and meta-analysis. World J Emerg Surg. 2023. doi:10.1186/s13017-023-00490-y [Level I: Systematic Review / Meta-Analysis]
• Wong CH, Khin LW, Heng KS, Tan KC, Low CO. The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med. 2004. doi:10.1097/01.ccm.0000129486.35458.7d [Level III: Diagnostic Cohort / Derivation & Validation Study]
• Stevens DL, Bisno AL, Chambers HF et al. Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2014. doi:10.1093/cid/ciu296 [Level V: Clinical Practice Guideline / Expert Consensus]
• Hakkarainen TW, Kopari NM, Pham TN, Evans HL. Necrotizing soft tissue infections: Review and current concepts in treatment, systems of care, and outcomes. Curr Probl Surg. 2014. doi:10.1067/j.cpsurg.2014.06.001 [Level V: Seminal Conceptual Review / Systems of Care Analysis]
• Evans L, Rhodes A, Alhazzani W et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021. doi:10.1007/s00134-021-06506-y [Level V: Evidence-Based Clinical Practice Guideline]

15. Master Class Pro-Tip

When performing the index debridement for necrotizing fasciitis, your goal is not skin preservation—it is definitive fascial clearance. Always carry your fascial incisions at least 4 to 5 cm beyond any visibly necrotic or non-adherent fascia until you encounter firm, glistening, actively bleeding fascia that resists digital separation. Apply gentle traction to the skin edges and probe the subfascial cleft with your index finger; if the plane dissects without resistance, your debridement is inadequate. Finally, never attempt primary closure or place permanent synthetic meshes during the acute phase. Pack the wound open with negative pressure therapy and formally book your 24-hour second look on the operating room slate before extubating the patient.

Master Class Surgical Pearl: Intraoperative Margin Delineation and Second-Look Discipline